| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.1 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |